Gonzalez-Angulo AM - Search Results

1

Present-day locoregional control in patients with t1 or t2 breast cancer with 0 and 1 to 3 positive lymph nodes after mastectomy without radiotherapy.

Sharma R, Bedrosian I, Lucci A, Hwang RF, Rourke LL, Qiao W, Buchholz TA, Kronowitz SJ, Krishnamurthy S, Babiera GV, Gonzalez-Angulo AM, Meric-Bernstam F, Mittendorf EA, Hunt KK, Kuerer HM. Sharma R, et al. Ann Surg Oncol. 2010 Nov;17(11):2899-908. doi: 10.1245/s10434-010-1089-x. Epub 2010 May 5. Ann Surg Oncol. 2010. PMID: 20443145 Free PMC article.

2

Factors predictive of distant metastases in patients with breast cancer who have a pathologic complete response after neoadjuvant chemotherapy.

Gonzalez-Angulo AM, McGuire SE, Buchholz TA, Tucker SL, Kuerer HM, Rouzier R, Kau SW, Huang EH, Morandi P, Ocana A, Cristofanilli M, Valero V, Buzdar AU, Hortobagyi GN. Gonzalez-Angulo AM, et al. J Clin Oncol. 2005 Oct 1;23(28):7098-104. doi: 10.1200/JCO.2005.11.124. J Clin Oncol. 2005. PMID: 16192593

3

The safety of breast-conserving surgery in patients who achieve a complete pathologic response after neoadjuvant chemotherapy.

Peintinger F, Symmans WF, Gonzalez-Angulo AM, Boughey JC, Buzdar AU, Yu TK, Hunt KK, Singletary SE, Babiera GV, Lucci A, Meric-Bernstam F, Kuerer HM. Peintinger F, et al. Cancer. 2006 Sep 15;107(6):1248-54. doi: 10.1002/cncr.22111. Cancer. 2006. PMID: 16862596 Free article.

4

Postmastectomy radiation improves the outcome of patients with locally advanced breast cancer who achieve a pathologic complete response to neoadjuvant chemotherapy.

McGuire SE, Gonzalez-Angulo AM, Huang EH, Tucker SL, Kau SW, Yu TK, Strom EA, Oh JL, Woodward WA, Tereffe W, Hunt KK, Kuerer HM, Sahin AA, Hortobagyi GN, Buchholz TA. McGuire SE, et al. Int J Radiat Oncol Biol Phys. 2007 Jul 15;68(4):1004-9. doi: 10.1016/j.ijrobp.2007.01.023. Epub 2007 Apr 6. Int J Radiat Oncol Biol Phys. 2007. PMID: 17418973 Free PMC article.

5

Low locoregional failure rates in selected breast cancer patients with tumor-positive sentinel lymph nodes who do not undergo completion axillary dissection.

Hwang RF, Gonzalez-Angulo AM, Yi M, Buchholz TA, Meric-Bernstam F, Kuerer HM, Babiera GV, Tereffe W, Liu DD, Hunt KK. Hwang RF, et al. Cancer. 2007 Aug 15;110(4):723-30. doi: 10.1002/cncr.22847. Cancer. 2007. PMID: 17587208 Free article.

6

Combined use of clinical and pathologic staging variables to define outcomes for breast cancer patients treated with neoadjuvant therapy.

Jeruss JS, Mittendorf EA, Tucker SL, Gonzalez-Angulo AM, Buchholz TA, Sahin AA, Cormier JN, Buzdar AU, Hortobagyi GN, Hunt KK. Jeruss JS, et al. J Clin Oncol. 2008 Jan 10;26(2):246-52. doi: 10.1200/JCO.2007.11.5352. Epub 2007 Dec 3. J Clin Oncol. 2008. PMID: 18056680

7

Estrogen/progesterone receptor negativity and HER2 positivity predict locoregional recurrence in patients with T1a,bN0 breast cancer.

Albert JM, Gonzalez-Angulo AM, Guray M, Sahin A, Strom EA, Tereffe W, Woodward WA, Tucker SL, Hunt KK, Hortobagyi GN, Buchholz TA. Albert JM, et al. Int J Radiat Oncol Biol Phys. 2010 Aug 1;77(5):1296-302. doi: 10.1016/j.ijrobp.2009.12.011. Epub 2010 May 14. Int J Radiat Oncol Biol Phys. 2010. PMID: 20472353

8

Impact of progression during neoadjuvant chemotherapy on surgical management of breast cancer.

Caudle AS, Gonzalez-Angulo AM, Hunt KK, Pusztai L, Kuerer HM, Mittendorf EA, Hortobagyi GN, Meric-Bernstam F. Caudle AS, et al. Ann Surg Oncol. 2011 Apr;18(4):932-8. doi: 10.1245/s10434-010-1390-8. Ann Surg Oncol. 2011. PMID: 21061075 Free PMC article.

9

Classification of ipsilateral breast tumor recurrences after breast conservation therapy can predict patient prognosis and facilitate treatment planning.

Yi M, Buchholz TA, Meric-Bernstam F, Bedrosian I, Hwang RF, Ross MI, Kuerer HM, Luo S, Gonzalez-Angulo AM, Buzdar AU, Symmans WF, Feig BW, Lucci A, Huang EH, Hunt KK. Yi M, et al. Ann Surg. 2011 Mar;253(3):572-9. doi: 10.1097/SLA.0b013e318208fc2a. Ann Surg. 2011. PMID: 21209588 Free PMC article.

10

Patients with only 1 positive hormone receptor have increased locoregional recurrence compared with patients with estrogen receptor-positive progesterone receptor-positive disease in very early stage breast cancer.

Albert JM, Gonzalez-Angulo AM, Guray M, Sahin A, Tereffe W, Woodward WA, Strom EA, Hunt KK, Tucker SL, Buchholz TA. Albert JM, et al. Cancer. 2011 Apr 15;117(8):1595-601. doi: 10.1002/cncr.25694. Epub 2010 Nov 8. Cancer. 2011. PMID: 21472707 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

266 results

Search Page